KIMBERLY MARSZALEK: Open Payments
NPI 1740963537 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 10 payments from 8 companies in 2025. Trend: 2023 $386 · 2024 $1,845 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| Cleerly, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $22 |
| Boston Scientific Corporation | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| CVRx, Inc. | 1 | $11 |
Products named: Cleerly Ischemia, REPATHA, WATCHMAN FLX, LifeVest, Kerendia, JARDIANCE, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
